UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme

The Journal of biological chemistry, 2009-05, Vol.284 (21), p.14177-14188

2009

Link zum Volltext

Verfügbarkeit prüfen

Protective Role of Cys-178 against the Inactivation and Oligomerization of Human Insulin-degrading Enzyme by Oxidation and Nitrosylation

The Journal of biological chemistry, 2009-12, Vol.284 (49), p.34005-34018

2009

Link zum Volltext

Verfügbarkeit prüfen

Signaling through CD43 regulates CD4 T-cell trafficking

Blood, 2007-10, Vol.110 (8), p.2974-2982

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading EnzymeS

The Journal of biological chemistry, 2009-05, Vol.284 (21), p.14177-14188

2009

Link zum Volltext

Verfügbarkeit prüfen

Reactive Species‐Mediated Covalent Modification of cGMP‐Protein Kinase I

The FASEB journal, 2009-04, Vol.23 (S1)

2009

Link zum Volltext

Verfügbarkeit prüfen

Human commensals producing a novel antibiotic impair pathogen colonization

Nature (London), 2016-07, Vol.535 (7613), p.511-516

2016

Link zum Volltext

Verfügbarkeit prüfen

The Marine Microbial Eukaryote Transcriptome Sequencing Project (MMETSP): illuminating the functional diversity of eukaryotic life in the oceans through transcriptome sequencing

PLoS biology, 2014-06, Vol.12 (6), p.e1001889

2014

Link zum Volltext

Verfügbarkeit prüfen

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

Nature (London), 2016-04, Vol.532 (7598), p.250-254

2016

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2020-05, Vol.395 (10236), p.1558-1568

2020

Link zum Volltext

Verfügbarkeit prüfen

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Clinical cancer research, 2016-06, Vol.22 (12), p.2908-2918

2016

Link zum Volltext

Verfügbarkeit prüfen

The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight

Science (American Association for the Advancement of Science), 2019-04, Vol.364 (6436)

2019

Link zum Volltext

Verfügbarkeit prüfen

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations

Journal of clinical oncology, 2019-11, Vol.37 (33), p.3142-3151

2019

Link zum Volltext

Verfügbarkeit prüfen

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations

Clinical cancer research, 2018-11, Vol.24 (21), p.5347-5356

2018

Link zum Volltext

Verfügbarkeit prüfen

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Clinical cancer research, 2016-11, Vol.22 (22), p.5487-5496

2016

Link zum Volltext

Verfügbarkeit prüfen

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

Clinical cancer research, 2016-10, Vol.22 (19), p.4848-4858

2016

Link zum Volltext

Verfügbarkeit prüfen

Gremlin 2 regulates distinct roles of BMP and Endothelin 1 signaling in dorsoventral patterning of the facial skeleton

Development (Cambridge), 2011-12, Vol.138 (23), p.5147-5156

2011

Link zum Volltext

Verfügbarkeit prüfen

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells

Clinical cancer research, 2014-03, Vol.20 (6), p.1601-1609

2014

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial

The Lancet (British edition), 2022-10, Vol.400 (10358), p.1117-1129

2022

Link zum Volltext

Verfügbarkeit prüfen

Decomposing Dynamic Risks into Risk Components

Management science, 2020-12, Vol.66 (12), p.5738-5756

2020

Link zum Volltext

Verfügbarkeit prüfen

DNA damage alters nuclear mechanics through chromatin reorganization

Nucleic acids research, 2021-01, Vol.49 (1), p.340

2021

Link zum Volltext

Verfügbarkeit prüfen

Combinatorial roles for BMPs and Endothelin 1 in patterning the dorsal-ventral axis of the craniofacial skeleton

Development (Cambridge), 2011-12, Vol.138 (23), p.5135-5146

2011

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

The Lancet (British edition), 2023-09, Vol.402 (10404), p.798-808

2023

Link zum Volltext

Verfügbarkeit prüfen

Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing

Journal of allergy and clinical immunology, 2024-01, Vol.153 (1), p.297-308.e12

2024

Link zum Volltext

Verfügbarkeit prüfen

A directional tuning map of Drosophila elementary motion detectors

Nature (London), 2013-08, Vol.500 (7461), p.212-216

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(67)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme

Protective Role of Cys-178 against the Inactivation and Oligomerization of Human Insulin-degrading Enzyme by Oxidation and Nitrosylation

Signaling through CD43 regulates CD4 T-cell trafficking

Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading EnzymeS

Reactive Species‐Mediated Covalent Modification of cGMP‐Protein Kinase I

Human commensals producing a novel antibiotic impair pathogen colonization

The Marine Microbial Eukaryote Transcriptome Sequencing Project (MMETSP): illuminating the functional diversity of eukaryotic life in the oceans through transcriptome sequencing

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity

Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

Gremlin 2 regulates distinct roles of BMP and Endothelin 1 signaling in dorsoventral patterning of the facial skeleton

Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A-Specific T Cells

Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial

Decomposing Dynamic Risks into Risk Components

DNA damage alters nuclear mechanics through chromatin reorganization

Combinatorial roles for BMPs and Endothelin 1 in patterning the dorsal-ventral axis of the craniofacial skeleton

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing

A directional tuning map of Drosophila elementary motion detectors

Aktive Filter

Suchergebnisse filtern